These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Medication errors related to product names. Santell JP; Cousins DD Jt Comm J Qual Patient Saf; 2005 Nov; 31(11):649-54. PubMed ID: 16335066 [TBL] [Abstract][Full Text] [Related]
47. Prevention strategies to identify LASA errors: building and sustaining a culture of patient safety. Lizano-Díez I; Figueiredo-Escribá C; Piñero-López MÁ; Lastra CF; Mariño EL; Modamio P BMC Health Serv Res; 2020 Jan; 20(1):63. PubMed ID: 31996197 [TBL] [Abstract][Full Text] [Related]
48. Special Considerations for Proprietary Name Review: Focus on Products That May Be Prescribed "As Directed". Rider BB; Mehta H; Merchant L Ther Innov Regul Sci; 2019 May; 53(3):381-386. PubMed ID: 29929377 [TBL] [Abstract][Full Text] [Related]
49. A systematic literature review of LASA error interventions. Bryan R; Aronson JK; Williams AJ; Jordan S Br J Clin Pharmacol; 2021 Feb; 87(2):336-351. PubMed ID: 33197079 [TBL] [Abstract][Full Text] [Related]
50. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives. Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428 [TBL] [Abstract][Full Text] [Related]
51. Evaluating the Potential Severity of Look-Alike, Sound-Alike Drug Substitution Errors in Children. Basco WT; Garner SS; Ebeling M; Freeland KD; Hulsey TC; Simpson K Acad Pediatr; 2016 Mar; 16(2):183-91. PubMed ID: 26946271 [TBL] [Abstract][Full Text] [Related]
52. Confusion over similar drug names. Problems and solutions. Aronson JK Drug Saf; 1995 Mar; 12(3):155-60. PubMed ID: 7619327 [TBL] [Abstract][Full Text] [Related]
54. A comparison of the effects of different typographical methods on the recognizability of printed drug names. Or CK; Wang H Drug Saf; 2014 May; 37(5):351-9. PubMed ID: 24718712 [TBL] [Abstract][Full Text] [Related]
56. Tallman lettering as a strategy for differentiation in look-alike, sound-alike drug names: the role of familiarity in differentiating drug doppelgangers. DeHenau C; Becker MW; Bello NM; Liu S; Bix L Appl Ergon; 2016 Jan; 52():77-84. PubMed ID: 26360197 [TBL] [Abstract][Full Text] [Related]
57. Tall man lettering application in medication information systems as a quality and safety strategy in hospital organization. Iglesias Gomez R; Font Noguera I; Correa Ballester M; Ruiz Caldes MJ; Poveda Andres JL J Clin Pharm Ther; 2022 Oct; 47(10):1570-1575. PubMed ID: 35641241 [TBL] [Abstract][Full Text] [Related]
58. Detection of potential look-alike/sound-alike medication errors using Veterans Affairs administrative databases. Zacher JM; Cunningham FE; Zhao X; Burk ML; Moore VR; Good CB; Glassman PA; Aspinall SL Am J Health Syst Pharm; 2018 Oct; 75(19):1460-1466. PubMed ID: 30257842 [TBL] [Abstract][Full Text] [Related]
59. The INN global nomenclature of biological medicines: A continuous challenge. Robertson JS; Chui WK; Genazzani AA; Malan SF; López de la Rica Manjavacas A; Mignot G; Thorpe R; Balocco R; Rizzi M Biologicals; 2019 Jul; 60():15-23. PubMed ID: 31130314 [TBL] [Abstract][Full Text] [Related]
60. Sound-alike and look-alike drugs: an overdue opportunity to reduce medical errors. Propp DA Acad Emerg Med; 2000 Nov; 7(11):1334-5. PubMed ID: 11073488 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]